Cl--ATPase in the CNS is a candidate for an outwardly directed neuronal Cl-
transporter requiring phosphatidylinositol-4-phosphate (PI4P) for its opti
mal activity. To test its pathophysiological changes in a phosphatidylinosi
tol (PI) metabolism disorder, the effects of neurotoxic factors in Alzheime
r's disease (AD), amyloid beta proteins (A betas), on the Cl--ATPase activi
ty were examined using primary cultured rat hippocampal neurons. Amyloid be
ta proteins (1-40, 1-42 and 25-35) concentration-dependently (1-100 nM) and
time-dependently (from 1 h to 6 day) decreased Cl--ATPase activity and ele
vated intracellular Cl- concentrations ([Cl-](i)), A beta 25-35 being the m
ost potent. Addition of inositol or 8-Br-cyclic GMP completely reversed the
se A beta -induced changes. The recoveries in enzyme activity were attenuat
ed by an inhibitor of PI 4-kinase, 10 muM wortmannin or 20 mum quercetin, b
ut not by a PI 3-kinase inhibitor, 50 nM wortmannin or 10 muM LY294002. The
PI, PIP and PIP2 levels of the plasma membrane-rich fraction were lower in
the A beta -treated cells as compared with each control. In the A beta -ex
posed culture, but not in control, stimulation by 10 tm glutamate for 10 mi
n significantly increased fragmentation of DNA and decreased cell viability
. Addition of inositol or 8-Br-cyclic GMP prevented the effect of A beta -t
reatment on the neurotoxicity of glutamate. Thus, A betas reduce neuronal C
l--ATPase activity, resulting in an increase in [Cl-](i) probably by loweri
ng PI4P levels, and this may reflect a pre-apoptotic condition in early pat
hophysiological profiles of AD.